3rd Circ. Pay-For-Delay Ruling Opens Door To High Court
By Melissa Lipman ( July 16, 2012, 7:50 PM EDT) -- The Third Circuit ruled Monday that payments from pharmaceutical makers to generics companies to settle patent litigation are evidence that a deal might violate federal antitrust law, rejecting the more lenient standard applied by other circuits and creating an opening for the long-simmering pay-for-delay debate to reach the U.S. Supreme Court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.